Arbutus Biopharma Corp (ABUS) Financials

$5.15

$0.03 (0.59%)

As on 04-Sep-2026 19:24EDT

Market cap

$1,020 Mln

Revenue (TTM)

$182 Mln

P/E Ratio

6.5

P/B Ratio

3.9

Div. Yield

0 %

Annual
Quarterly

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-39.64	-64.85	-85.94	-35.36	-67.53
Cash Flow from Investing Activities	--	15.58	22.95	50.77	-74.94	-12.68
Cash from Financing Activities	--	5.72	52.00	30.65	31.81	137.24
Net Cash Inflow / Outflow	--	--	--	--	-78.48	57.03

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	0.78	-0.17	-0.37	-0.43	-0.45	-0.75
Cash EPS ($)	--	-0.17	-0.36	-0.42	-0.44	-0.74
Adjusted Book Value ($)	--	0.40	0.51	0.63	0.89	1.67
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.21	-0.34	-0.51	-0.23	-0.67
Free Cash Flow per Share ($)	--	-0.21	-0.34	-0.52	-0.23	-0.67

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-36.37	-64.08	-55.16	-41.13	-48.74
ROE (%)	91.29	-38.52	-68.76	-59.99	-45.35	-56.19
ROA (%)	79.37	-29.60	-50.65	-42.88	-34.74	-44.65
EBIT Margin (%)	84.27	-237.19	-1,130.82	-399.04	-162.19	-667.91
Net Margin (%)	84.23	-237.88	-1,133.04	-401.57	-168.63	-685.67
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	1,078.78	1.28	-0.66	-0.54	2.55	0.59
EBIT Growth (%)	367.23	52.13	3.60	-14.39	13.77	-22.86
Net Profit Growth (%)	382.12	52.09	4.02	-4.89	8.91	-19.61
EPS Growth (%)	374.07	0.52	0.15	0.04	0.40	-0.10
Book Value Growth (%)	203.81	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	6.52	-27.51	-8.88	-5.78	-5.18	-5.17
Price / Book Value	3.92	12.04	6.38	3.97	2.63	2.33
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	6.01	-25.25	-7.38	-4.28	-3.64	-3.60
Close Price ($)	4.80	4.81	3.27	2.50	2.33	3.89
High Price ($)	5.07	5.07	4.73	3.15	4.03	6.50
Low Price ($)	3.06	2.71	2.21	1.69	1.85	2.43
Market Cap ($ Cr)	1,020.24	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.05	0.06	0.08	0.09	0.11
Short term debt to equity ratio	0.00	0.01	0.00	0.00	0.00	0.00
Current Ratio	81.42	15.73	8.15	5.87	4.60	14.32
Quick Ratio	81.42	--	--	5.95	4.69	14.71
Interest Coverage	2,014.87	-344.37	-509.36	-157.71	-36.67	-25.69

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	98.91	12.41	39.04	9.79	3.46	8.18
Asset Turnover	0.94	0.12	0.04	0.11	0.20	0.06
Receivable days	--	53.89	123.85	31.49	10.54	36.75
Inventory Days	--	--	-470.06	-11.52	-936.67	-788.53
Payable days	--	1,755.31	733.01	16.71	856.69	642.57
Cash Conversion Cycle	--	--	-1,079.22	3.26	-1,782.82	-1,394.35

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.